Prostate cancer: GHRH antagonists could be effective in CRPC treatment

About this comment from original article: Rick, F. G. et al. - Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of
ERK and Akt kinases. Proc. Natl Acad. Sci. USA 109, 1655–1660 (2012).

See also:

- Somatostatin in oncology, the overlooked evidences in the "Some additional publications about hGH/GH-GHRH/GHRF/GRF" section;

- The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature;